165 related articles for article (PubMed ID: 21156047)
41. Clusterin in Alzheimer's disease.
Wu ZC; Yu JT; Li Y; Tan L
Adv Clin Chem; 2012; 56():155-73. PubMed ID: 22397031
[TBL] [Abstract][Full Text] [Related]
42. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
43. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
[TBL] [Abstract][Full Text] [Related]
44. Clusterin as a Potential Biomarker of Obesity-Related Alzheimer's Disease Risk.
Bradley D
Biomark Insights; 2020; 15():1177271920964108. PubMed ID: 33110346
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
46. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
Reinvang I; Espeseth T; Westlye LT
Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
[TBL] [Abstract][Full Text] [Related]
47. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
Wozniak MA; Mee AP; Itzhaki RF
J Pathol; 2009 Jan; 217(1):131-8. PubMed ID: 18973185
[TBL] [Abstract][Full Text] [Related]
48. Functional and structural properties of lipid-associated apolipoprotein J (clusterin).
Calero M; Tokuda T; Rostagno A; Kumar A; Zlokovic B; Frangione B; Ghiso J
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):375-83. PubMed ID: 10567218
[TBL] [Abstract][Full Text] [Related]
49. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.
DeMattos RB; Brendza RP; Heuser JE; Kierson M; Cirrito JR; Fryer J; Sullivan PM; Fagan AM; Han X; Holtzman DM
Neurochem Int; 2001; 39(5-6):415-25. PubMed ID: 11578777
[TBL] [Abstract][Full Text] [Related]
50. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.
Holtzman DM
J Mol Neurosci; 2004; 23(3):247-54. PubMed ID: 15181253
[TBL] [Abstract][Full Text] [Related]
51. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
Misra A; Chakrabarti SS; Gambhir IS
Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
[TBL] [Abstract][Full Text] [Related]
52. Impaired Innate Immunity Mechanisms in the Brain of Alzheimer's Disease.
Romagnoli M; Porcellini E; Carbone I; Veerhuis R; Licastro F
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046242
[TBL] [Abstract][Full Text] [Related]
53. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
54. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
Bales KR
Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
[TBL] [Abstract][Full Text] [Related]
55. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
56. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
[TBL] [Abstract][Full Text] [Related]
58. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
Harris SA; Harris EA
J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
[TBL] [Abstract][Full Text] [Related]
59. Genetic risk factor clustering within and across neurodegenerative diseases.
Koretsky MJ; Alvarado C; Makarious MB; Vitale D; Levine K; Bandres-Ciga S; Dadu A; Scholz SW; Sargent L; Faghri F; Iwaki H; Blauwendraat C; Singleton A; Nalls M; Leonard H
Brain; 2023 Nov; 146(11):4486-4494. PubMed ID: 37192343
[TBL] [Abstract][Full Text] [Related]
60. Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegeneration.
Olivera E; Sáez A; Carniglia L; Caruso C; Lasaga M; Durand D
Neural Regen Res; 2023 Jul; 18(7):1404-1410. PubMed ID: 36571334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
